Thermo Fisher Scientific Completes Acquisition of Advanced Bioprocessing from BD
WALTHAM, Mass., Oct. 25, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today completed its previously announced acquisition of the Advanced Bioprocessing business from BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, for $477 million in cash, subject to post-closing adjustments. The... Read more